Noam VanderWalde, MD, is a nationally recognized expert in the treatment of older cancer patients with radiation therapy.
Titles and Roles
- Director of Clinical Research, Department of Radiation Oncology, West Cancer Center
- Assistant Professor, the University of Tennessee Health Science Center
Areas of Expertise
- Breast cancer
- Head and neck
- Health Services Research
Noam VanderWalde, MD, is considered a national expert in the treatment of older cancer patients with radiation and sits on multiple national committees, including the Senior Adult Oncology Committee for the National Comprehensive Cancer Network (NCCN) and the Cancer in the Elderly Committee for the Alliance for Clinical Trials Cooperative Group. He has been an invited speaker at multiple national meetings, such as the Bladder Cancer Advocacy Network and at the Alliance for Clinical Trials.
Dr. VanderWalde is a member of a number of national groups, including the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), The American Medical Association (AMA), Alpha Omega Alpha (AOA), Southwest Oncology Cooperative Group (SWOG), the Alliance for Clinical Trials in Oncology, and the Cancer and Aging Research Group (CARG).
Dr. VanderWalde hopes to improve the care of the patients at West Cancer Center by giving them access to the best available investigator initiated and national cancer studies. He hopes this will allow West Cancer Center patients to not only improve their outcomes, but also improve the outcomes of future cancer patients as well.
Education and Training
Dr. VanderWalde graduated Magna Cum Laude with a bachelor’s degree in History from the University of Pennsylvania. He completed his medical degree at the University of Maryland and was nominated to the Alpha Omega Alpha honors medical society. He completed his Radiation Oncology residency at the University of North Carolina. Dr. VanderWalde is board certified by the American Board of Radiology in Radiation Oncology.
Dr. VanderWalde has been the recipient of multiple research awards, including:
- The Roentgen Resident Research Award, 2014
- Conquer Cancer Foundation of ASCO Young Investigator Award, 2014
- Lineberger Comprehensive Cancer Center Clinical/Translational Developmental Research Award, 2013
- The Alpha Omega Alpha Postgraduate Award, 2012
Dr. VanderWalde is currently the primary investigator on multiple investigator initiated studies, including:
- PI: The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older
- Co-PI: Predicting Tolerance to Radiation Therapy in Older Adults with Cancer
- Co-PI: Radiation Adherence/Toxicity in Patients with Non-Ovarian Gynecological Cancers
- Site-PI: Neoadjuvant Chemoradiotherapy with CRLX-101 and Capecitabine for Rectal Cancer
Dr. VanderWalde has published numerous peer reviewed articles and has presented data at many national and international meetings on topics such as geriatric, head and neck cancer, breast cancer, bladder cancer, and health services research.
To view Dr. VanderWalde’s recent publications, click here.